Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 2
2021 1
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer.
Price JM, Mistry HB, Betts G, Cheadle EJ, Dixon L, Garcez K, Illidge T, Iyizoba-Ebozue Z, Lee LW, McPartlin A, Prestwich RJD, Papageorgiou S, Pritchard DJ, Sykes A, West CM, Thomson DJ. Price JM, et al. Among authors: iyizoba ebozue z. J Clin Oncol. 2022 Jul 10;40(20):2203-2212. doi: 10.1200/JCO.21.01991. Epub 2022 Apr 6. J Clin Oncol. 2022. PMID: 35385334 Free PMC article.
Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharyngeal cancer: A multi-centre study.
Price JM, West CM, Dixon LM, Iyizoba-Ebozue Z, Garcez K, Lee LW, McPartlin A, Slevin F, Sykes A, Prestwich RJD, Thomson DJ. Price JM, et al. Among authors: iyizoba ebozue z. Radiother Oncol. 2022 Jul;172:111-117. doi: 10.1016/j.radonc.2022.05.013. Epub 2022 May 17. Radiother Oncol. 2022. PMID: 35595173
Corrigendum to "Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharynx cancer: A multi-centre study" [Radiother. Oncol. 172 (2022) 111-117].
Price JM, West CM, Dixon LM, Iyizoba-Ebozue Z, Garcez K, Lee LW, McPartlin A, Williams G, Slevin F, Sykes A, Prestwich RJD, Thomson DJ. Price JM, et al. Among authors: iyizoba ebozue z. Radiother Oncol. 2022 Dec;177:163. doi: 10.1016/j.radonc.2022.10.014. Epub 2022 Nov 14. Radiother Oncol. 2022. PMID: 36395551 No abstract available.
"Why am I still suffering?": Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapy.
Iyizoba-Ebozue Z, Nicklin E, Price J, Prestwich R, Brown S, Hall E, Lilley J, Lowe M, Thomson DJ, Slevin F, Murray L, Boele F. Iyizoba-Ebozue Z, et al. Tech Innov Patient Support Radiat Oncol. 2024 Mar 8;30:100241. doi: 10.1016/j.tipsro.2024.100241. eCollection 2024 Jun. Tech Innov Patient Support Radiat Oncol. 2024. PMID: 38510557 Free PMC article.